NAKYUNG JEON portrait
  • Adjunct Assistant Professor, Family And Preventive Medicine

Research Keywords

  • Pharmacoepidemiology
  • Health Outcomes Reserach
  • Health Care Quality and Patient Safety
  • Drug Safety

Presentations

  • Jeon N. Bussing R, Albogami Y, Winterstein AG. The role of mental disorder in teenage pregnancy among commercially insured girls aged 13-19 in the U.S. 2005 – 2014. 34rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management. August 22-26, 2018, Prague, Czech Republic. Pharmacoepi Drug Saf 2018;27(Suppl2):303. Poster, Presented, 08/2018.
  • Jeon N. Staley B, Henricksen C. Lipori G, Winterstein AG. Development of prediction model including modifiable risk factors for uncontrolled Clostridium Difficile infection using hospital electronic health records. 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management. August 26-30, 2017, Montreal, CA. Pharmacoepi Drug Saf 2017;26(Suppl2):610-611. Poster, Presented, 08/2017.
  • Jeon N. Staley B, Henricksen C, Xu D, Lipori G, Brumback B, Winterstein AG. Development of risk model to predict drug induced acute kidney injury in hospitalized patients. 32nd Conference of Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, Pharmacoepi Drug Saf 2016; 25(Suppl. 3):269. Presentation, Presented, 08/2016.
  • Jeon N. Staley B, Kenneth K, Winterstein AG. The Risk of Acute Kidney Injury of piperacillin-tazobactam plus vancomycin compared to cefepime plus vancomycin. 32nd Conference of Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, Pharmacoepi Drug Saf 2016; 25(Suppl. 3):270. Presentation, Presented, 08/2016.
  • Jeon N, Winterstein AG. Addition of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Risk of Acute Kidney Injury (AKI) in Hospitalized Patients Receiving Vancomycin. 31st Conference of Pharmacoepidemiology & Therapeutic Risk Management, Boston, U.S. Pharmacoepi Drug Saf 2015;24:410-411. Presentation, Presented, 08/2015.

Publications

  • Jeon N & Staley B, Henriksen C, Lipori PG, Winterstein AG. (2018). Development and validation of risk models to predict patients at higher risk of acute kidney injury among hospitalized patients receiving nephrotoxic medication. Am J Health Syst Pharm. Accepted, 09/2018.
  • Winterstein AG & Jeon N, Staley B, Henriksen C, Xu D, Lipori PG (2018). Development and validation of an automated algorithm for identifying patients at higher risk for drug-induced hypoglycemia using hospital electronic health records. Am J Health Syst Pharm. Accepted, 08/2018.
  • Jeon N & Sorokina M, Henriksen C, Staley B, Lipori PG, Winterstein AG (2017). Measurement of selected preventable adverse drug events in electronic health records: Toward developing a complexity score . Am J Health Syst Pharm. Vol. 74(22), 1865-1877. Published, 12/2017.
  • Winterstein AG & Staley B, Henriksen C, Xu D, Lipori PG, Jeon N (2017). Development and validation of a Complexity-Score to rank hospitalized patients at risk for preventable adverse drug events. Am J Health Syst Pharm. Vol. 74(23), 1970-1984. Published, 12/2017.
  • Jeon N & Staley B, Johnson T, Winterstein AG (2017). Identifying and characterizing preventable adverse drug events for prioritizing pharmacist intervention in hospitals. Am J Health Syst Pharm. Vol. 74(21), 1774-1783. Published, 11/2017.
  • Jeon N (2017). Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney function. Int J Antimicrob Agents. Vol. 50(1), 63-67. Published, 01/2017.